Johnson & Johnson (JNJ) Unit Cordis Corporation (JNJ) Facing Potential US Stent Supply Disruption
2/25/2011 6:52:26 AM
WSJ -- Johnson & Johnson's (JNJ) Cordis unit is facing a potential U.S. supply disruption for its Cypher heart stents because Abbott Laboratories (ABT) will soon stop supplying catheters most commonly used to install the tiny devices, Cordis confirmed Thursday.
|